Framework to assess, nudge generic drug makers to expand access to products
Jyothi Datta, writing for the Hindu Business Line, covers the Foundation's launch of the first ever analytical framework to assess manufacturers of generic and biosimilar medicine.
The article looks at some of the challenges relating to access to generic medicine and how the framework will assess, track and guide manufacturers’ efforts to expand access to their products in low- and middle-income countries (LMICs).
Read the article on the Hindu Business Line website.